Health-care workers who got the influenza vaccine were also protected from COVID-19 — but the effect might not last long. By Ewen Callaway Twitter Facebook Email Influenza vaccines have a surprising health benefit: they might also prevent COVID-19, particularly in its most severe forms1. ...
It’s not a newly developed vaccine made in a hurry using a new technology. They aren’t hearing a lot of expert disagreement or nonexpert rumors about the vaccine, or about the disease. The messaging they hear every year is pretty consistent. Flu is old news, and they know the drill....
ModernaannouncedFebruary 24 that it had shipped a booster vaccine candidate based on B.1.351 to the NIAID for a phase 1 trial. And Novavax, whose first-generation vaccine hasn’t been authorized yet in the US, announced January 28 it was working on developing a booster, a combination bivalen...
Health authorities had previously voiced optimism that a combo shot would boost uptake. Only19.5% of adultshave gotten an updatedbivalent COVID-19 boosterdose this past season, compared tonearly halfwho say they got a flu shot. A combo shot could also simplify an increasingly complex annual vacc...
We evaluate the impact of government-mandated proof of vaccination requirements for access to public venues and non-essential businesses on COVID-19 vaccine uptake. We find that the announcement of a mandate is associated with a rapid and significant surge in new vaccinations (a more than 60% ...
COVID vaccines at locations that usually offer flu vaccinations, such as a local pharmacy, doctor’s office, or health clinic. You can use the CDC-sponsoredVaccines.govtool to identify specific locations near you. You can perform a broad search or filter by age range and preferred vaccine. ...
The Centers for Disease Control and Prevention recommends everyone ages 6 months and older get an updated 2024–25 COVID vaccine in the fall. Johner Images/Getty Images When will the new COVID vaccines be available? Each autumn you get a ...
Pfizer has other standalone influenza programs still in development. The pharmaceutical giant previously reported positive preliminary Phase 3 results for a first-generation quadrivalent mRNA flu vaccine tested in adults ages 18 to 64. However, this vaccine did not meet efficacy goals in adults age ...
Trending Combo COVID-19 and Flu mRNA Vaccine Falls Short of Total Flu Protection News September 13, 2024 Receipt of COVID-19 Booster Dose Among Fully Vaccinated Pregnant Individuals Aged 18 to 49 Years by Key Demographics Research April 22, 2022...
Vaccine against the MERS coronavirus tested as safe and effective in phase Ib clinical trial Oct 21, 2024 In depth analysis explains why preschoolers are less likely to develop severe COVID-19 Oct 15, 2024 Survery: Public worry about RSV has faded, unlike flu and COVID-19 ...